The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.
Jitika Gupta- marketing director, BigMuscles Nutrition, talks to Shailja Tiwari about the brand’s strategy to expand its presence in India’s growing fitness supplement market.